We will discuss the industry trends by examining the pipeline by company, therapeutic area, disease, target and drug type, using data from Pharma Intelligence’s Phamaprojects. This report will focus on research and development as it is now, how it is changing and mutating, and where it has been headed during 2016 and will be in 2017.
It will be followed up by our annual supplement reviewing the New Active Substance launches for last year.
Join Alex Shimmings, Executive Editor, Europe, Commercial, Scrip, Pink Sheet, In Vivo and Ian Lloyd, Senior Director, Pharmaprojects and Data Integration - Citeline as they will share insight on the following key areas:
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: